Replies to post #27023 on CytoSorbents Corporation (CTSO)

[Good Sport]

It was an "Additive" treatment during the cell exchange protocol procedures (10 years ago). Dr June is still listed on Cytosorbent's web page as an "Advisor". I'm assuming he still is. Chan and Co. are "laser focused" on getting the blood thinner/filter trialed and fda'd so it's not likely were gonna see much pr on CAR-T. A congratulations for the 10 yr remission is due to all those players involved. Hope this "cure" doesn't get swept under the rug as it is huge imo!!! I think Norvartis needs to go on the speculative list to acquire Cytosorbents if there is one.

[kjpcrna]

“Although a majority of patients will achieve a complete response following a single infusion of CD19-targeted CAR-modified T cells (CD19 CAR T cells)2-4, the broad applicability of this treatment is hampered by severe cytokine release syndrome (CRS), which is characterized by fever, hypotension and respiratory insufficiency associated with elevated serum cytokines, including interleukin-6 (IL-6)”.
Goes on to state CRS can occur within days of T-cell infusion.